Featured Articles
-
Early Product Characterization De-Risks Biologics Development
6/12/2019
The relationship between physicochemical profile and biological activity — and how this relationship affects clinical performance — is key to informed decisions, accelerated development, and risk reduction.
-
Difficult-To-Purify And Difficult-To-Filter Small Molecules
11/3/2026
Poor filterability and stubborn impurities often trace back to the same molecular features, which changes how development teams approach scale-up for larger, structurally complex small molecules.
-
Selecting The Right Chromatography Strategy
11/3/2026
Difficult small molecule purifications rarely yield to one technique. Modeling, fraction mapping, and preparative HPLC each solve a different problem, and the right choice depends on the molecule.
-
Choosing The Right CDMO For Substance Development And Manufacturing
11/3/2026
Controlled substance programs demand licensing, closed-system custody, and inspection history well beyond GMP. Sponsors weighing partners must test technical depth against compliance infrastructure.
-
Optimizing Particle Properties For Difficult Small Molecules
11/3/2026
Crystal morphology and unexpected solid-state intermediates often decide whether a difficult small molecule filters, dries, and scales. Thermodynamic stability may not be the right target.
-
Bioconjugation Scale-Up: Data-Driven Strategies From 10 L To 500 L
10/23/2026
Data-driven scale-up of ADC bioconjugation depends on matching mixing and temperature conditions. Solvent compatibility of single-use components and production-scale economics round out the decisions.
-
Why Trusted Data, Connected Systems, And Smart Workflows Are The Future
10/16/2026
QC labs face rising sample volumes and tighter data expectations. Automation progress depends less on robotics than on standardization, connected data, early cross-functional planning, and more.
-
Science-Driven Risk Mitigation In Single-Use Drug Product Processing
10/16/2026
Explore how extractables and leachables from single-use systems can affect peptide stability, as well as how science-led approaches to component selection can reduce risk throughout manufacturing.
-
The Critical Role Of Excipients In GLP-1 Agonist Formulation Design
10/16/2026
Excipient selection shapes GLP-1 agonist formulations, from granulated buffers to carrier-based systems aimed at improving solubility and achieving targeted release in the intestine.
-
Navigating The Analytical Challenges Of Complex ADCs
10/14/2026
Antibody drug conjugates are expanding to deliver diverse therapeutic payloads. Advanced analytical strategies are required to characterize these evolving platforms.